United States Allogeneic Stem Cells Market Poised for Transformative Growth Amid Rising Demand for Advanced Regenerative Therapies 2025 | Top key players - MEDIPOST Co. Ltd., MiMedx Group Inc., Osiris Therapeutics Inc.

Market Size and Growth:

The Global Allogeneic Stem Cells Market size reached USD 0.9 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 2.0 billion by 2031, growing at a CAGR of 9.6% during the forecast period (2024-2031).

The Allogeneic Stem Cells Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/allogeneic-stem-cells-market?sz

The Allogeneic Stem Cells Market refers to the global industry focused on the production, distribution, and clinical application of stem cells derived from healthy donors for therapeutic purposes. These cells are used in regenerative medicine, tissue repair, and treatment of various diseases, including blood disorders, autoimmune conditions, and organ failures, offering standardized, off-the-shelf treatment solutions.

Recent Key Developments of United States (U.S):

September 2025: A key allogeneic cell therapy company reiterated that its products, including the FDA-approved mesenchymal stromal cell (MSC) therapy Ryoncil® (remestemcel-L-rknd), are manufactured from US donors in the US, designating them as US-origin products.

September 2025: A therapeutics company announced its President and CEO would present on a panel discussing the investment landscape and novel opportunities in the Induced Pluripotent Stem Cell (iPSC) space, highlighting its focus on allogeneic, off-the-shelf therapies using engineered induced mesenchymal stem cells (iMSC) for cancer and autoimmune disease.

September 2025: An allogeneic pluripotent stem cell-derived therapy for Parkinson's disease (bemdaneprocel/BRT-DA01) started treating the first patient in its Phase III trial (exPDdite-2) in the US, aiming to replace lost dopamine-producing neurons.

August 2025: The FDA's list of Approved Cellular and Gene Therapy Products updated to include a range of existing allogeneic products, such as various Hematopoietic Progenitor Cells (HPC) from cord blood (e.g., ALLOCORD, HEMACORD) and Ryoncil® (remestemcel-L-rknd). (Content current as of 08/15/2025).

July 2025: Ongoing shift in clinical trial focus towards allogeneic cell therapy candidates for various diseases, including cancer, genetic disorders, and autoimmune diseases, supported by increasing investment and government interest. (Based on Q3 2025 market analysis).

List of the Key Players in the Allogeneic Stem Cells Market:

STEMCELL Technologies Inc.
Lineage Cell Therapeutics Inc.
Takeda Pharmaceutical Co. Ltd.
Biosolution Co. Ltd.
Cynata Therapeutics Ltd.
JCR Pharmaceuticals Co. Ltd.
MEDIPOST Co. Ltd.
MiMedx Group Inc.
Osiris Therapeutics Inc.
Stempeutics Research Pvt. Ltd.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=allogeneic-stem-cells-market

Segments Covered in the Allogeneic Stem Cells Market:

By Product: PAdult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells.

By Cell Origin: Bone Marrow Stem Cells, Peripheral Blood Stem Cells, Cord Blood Stem Cells, Others.

By Application: Cardiovascular Disorders, Immunological Disorders, Cancers, Musculoskeletal Disorders, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/allogeneic-stem-cells-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Allogeneic Stem Cells market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Allogeneic Stem Cells Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Allogeneic Stem Cells market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Allogeneic Stem Cells Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Allogeneic Stem Cells Market in 2025?
◆ What is the projected growth rate of the Allogeneic Stem Cells Market through 2033?
◆ Who are the key players in the Allogeneic Stem Cells Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.